Global Hip Dysplasia Registry

ConditionsHip Dislocation, Congenital Hip Dysplasia, Congenital, Nonsyndromic Congenital Dysplasia of the Hip Congenital Hip Dislocation Congenital Hip Displacement Congenital Hip Dysplasia Dislocation of Hip, Congenital Dislocation, Congenital Hip Displacement, Congenital Hip Dysplasia, Congenital Hip Hip Displacement, Congenital Hip, Dislocation Of, Congenital

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-10

SponsorUniversity of British Columbia

About this trial

Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a "ball-and-socket" joint. When the femoral head (the "ball) is seated properly in the acetabulum (the "socket"), the hip is stable and can develop normally. However, when the femoral head is not well-seated, the hip can become unstable or dislocate. This instability or dislocation of the femoral head prevents the hip joint from developing normally during infancy and early childhood. If left undetected or untreated, it can lead to debilitating complications later in life.

Development of a comprehensive, prospective international registry for all infants and children with DDH will provide the potential to impact all infants born, not only in British Columbia, but around the world. The purpose of this initiative is to identify best practices and standardize treatment and management strategies in order to optimize clinical and functional outcomes for patients with DDH. This registry includes targeted specific outcomes that will be investigated, in addition to the general collection of data on all patients diagnosed with any form of DDH up to the age of 10 years.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Between the ages of 0 and 10 years at time of initial diagnosis

Referred for DDH screening due to specific risk factors OR diagnosed with DDH

Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging

Disqualifiers

Known or suspected neuromuscular, collagen, chromosomal or lower extremity congenital anomalies

Teratologic hip dislocation (syndromic-associated dislocations)

Over 10 years of age at initial diagnosis

Received prior treatment for DDH without appropriate imaging or documentation

Trial population

Patients who have been referred to a participating center for DDH risk factors or patients with diagnosed DDH will be included in the registry. Patients will be enrolled during one of their routine clinic appointments at one of the participating centers.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Observational
Other intervention
All groups will undergo observational data collection. No interventions will be made to patient care.

Treatment groups

5,000 Participants

are divided into 3 treatment groups

Group A: Arm I: Prospective from diagnosis1 intervention

Group B: Arm II: Prior treatment at center1 intervention

Group C: Arm III: Prior treatment at outside center1 intervention

Trial outcomes

Primary outcomes

Development of a general, prospective DDH registry with follow-up to skeletal maturity

Data will be collected from patients with or at risk of DDH to create a registry. Patients will be followed up until skeletal maturity.

Time frame